Immuno-Oncology and ADCs Market Overview The immuno-oncology and antibody–drug conjugates (ADCs) market represents one of the most dynamic and rapidly advancing segments of the global oncology therapeutics industry. Immuno-oncology focuses on harnessing the body’s immune system to recognize, target, and eliminate cancer cells, while ADCs combine the specificity of...